Canada-based all-mushroom producer Red Light Holland Corp. (OTCQB: TRUFF) filed its quarterly financial statements and management discussion and analysis for the three and six months ended Sept. 30, 2023.
Numbers show:
Psychedelics biotech Seelos Therapeutics (NASDAQ: SEEL) announced the pricing of a new underwritten public offering for an estimated $5.5 million in gross proceeds. The offering is expected to close on or about Dec. 1, 2023.
Open Book Extracts (OBX), a cannabinoid product manufacturer, has inked a term sheet to acquire Nucl3o, a processor of high-purity cannabinoid isolates, Benzinga Cannabis has learned exclusively.
Chorus Compliance, a subsidiary of SC Labs and a leader in cannabis business software solutions has announced its acquisition of Build My SOP, a company specializing in standard operating procedures and management software for the cannabis industry.